Finance

Lists
290650:KOSDAQ
L&C Bio Co Ltd
â‚©58,100.00
+3.38%
(+1,900.00) 1D
Jul 27, 3:30:26 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 290650...
Open
â‚©57,900
High
â‚©58,800
Low
â‚©56,300
Mkt. cap
1.57T
Avg. vol.
336.56K
Volume
161.22K
Dividend
0.09%
Quarterly dividend
â‚©13
Ex-dividend date
Dec 27, 2023
52-wk high
â‚©125,000
52-wk low
â‚©29,100
EPS
-â‚©5,747
Shares outstanding
26.97M
No. of employees
172
Open
â‚©57,900
High
â‚©58,800
Low
â‚©56,300
Mkt. cap
1.57T
Avg. vol.
336.56K
Volume
161.22K
Dividend
0.09%
Quarterly dividend
â‚©13
Ex-dividend date
Dec 27, 2023
52-wk high
â‚©125,000
52-wk low
â‚©29,100
EPS
-â‚©5,747
Shares outstanding
26.97M
No. of employees
172
News stories
From sources across the web
About L&C Bio Co Ltd
CEOLee Hwan-chul
Employees172
Founded2011
Headquarters-
SectorBiotechnology
Websitelncbio.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
20.58B
22.56B
24.67B
30.29B
Cost of goods sold
11.21B
9.38B
11.58B
11.94B
Cost of revenue
11.21B
9.38B
11.58B
11.94B
Research and development expenses
931.57M
880.96M
1.05B
1.25B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.73B
8.36B
8.91B
10.14B
Operating expense
9.62B
10.28B
12.13B
12.35B
Total operating expenses
20.83B
19.66B
23.71B
24.30B
Operating income
-245.10M
2.90B
954.55M
6.00B
Other non operating income
-14.20B
-54.17B
-16.26B
-2.85B
EBT including unusual items
-14.03B
-51.33B
-94.05B
3.01B
EBT excluding unusual items
-14.45B
-51.27B
-19.64B
3.15B
Income tax expense
73.57M
7.33M
-21.53B
286.59M
Effective tax rate
-0.52%
-0.01%
22.89%
9.51%
Other operating expenses
-
-
-
-
Net income
-13.73B
-51.46B
-72.56B
2.60B
Net profit margin
-66.72%
-228.14%
-294.12%
8.59%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1.64B
-
Interest expense
-
-
-5.87B
-
Net interest expenses
-
-
-4.22B
-
Depreciation and amortization charges
820.40M
885.12M
922.46M
787.97M
EBITDA
1.77B
4.98B
3.18B
8.09B
Gain or loss from assets sale
-140.40M
576.38M
-528.80M
-18.11M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer